OLEPTISS

This brand name is authorized in Nigeria.

Active ingredients

The drug OLEPTISS contains one active pharmaceutical ingredient (API):

1
UNII N7U69T4SZR - OLANZAPINE
 

Olanzapine is an antipsychotic, antimanic and mood stabilising agent that demonstrates a broad pharmacologic profile across a number of receptor systems.

 
Read more about Olanzapine

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-100403 Film coated tablet Oleptiss 180mg Film-coated tablet TAB_FILM_COATED 180 mg 3x10 106 NF-PP-275133 Oleptiss 180mg Film-coated tablet Deferasirox Active Ingredient - Deferasirox 180mg. Excipients - Microcrystalline cellulose; crospovidone; povidone (K30); magnesium stearate; colloidal silicon dioxide; poloxamer 188; coating material: hypromellose; titanium dioxide (E171); polyethylene glycol (4000); talc; FD&C blue 2/Indigo carminine aluminum lake (E132) Drugs Imported Products 3x10 Prescription Only Medicine (POM) 8/10/2022 NOVARTIS NIGERIA LIMITED, LANDMARK BUILDING 52/54 ISAAC JOHN STREET IKEJA-GRA LAGOS LAGOS 2.34707E+12 arit.onwusah@novartis.com Sandoz S.R.L., Str. Livezeni nr.7A, 540472, Targu Mures, Romania, Str. Livezeni nr.7A, 540472, Targu Mures, Romania, Romania 25/05/2023
A4-100404 Film coated tablet Oleptiss 90mg Film-coated tablet TAB_FILM_COATED 90 mg 3x10 107 NF-PP-276629 Oleptiss 90mg Film-coated tablet Deferasirox Deferasirox 90mg. Excipients - Microcrystalline cellulose; crospovidone; povidone (K30); magnesium stearate; colloidal silicon dioxide; poloxamer 188; coating material: hypromellose; titanium dioxide (E171); polyethylene glycol (4000); talc; FD&C blue 2/Indigo carminine aluminum lake (E132) Drugs Imported Products 3X10 Prescription Only Medicine (POM) 8/19/2022 NOVARTIS NIGERIA LIMITED, LANDMARK BUILDING 52/54 ISAAC JOHN STREET IKEJA-GRA LAGOS LAGOS 2.34707E+12 arit.onwusah@novartis.com Sandoz S.R.L., Str. Livezeni nr.7A, 540472, Targu Mures, Romania, Str. Livezeni nr.7A, 540472, Targu Mures, Romania, Romania 25/05/2023
A4-100405 Film coated tablet Oleptiss 360mg Film-coated tablet TAB_FILM_COATED 360 mg 3x10 108 NF-PP-276632 Oleptiss 360mg Film-coated tablet Deferasirox Deferasirox 360mg. Excipients - Microcrystalline cellulose; crospovidone; povidone (K30); magnesium stearate; colloidal silicon dioxide; poloxamer 188; coating material: hypromellose; titanium dioxide (E171); polyethylene glycol (4000); talc; FD&C blue 2/Indigo carminine aluminum lake (E132) Drugs Imported Products 3X10 Prescription Only Medicine (POM) 8/19/2022 NOVARTIS NIGERIA LIMITED, LANDMARK BUILDING 52/54 ISAAC JOHN STREET IKEJA-GRA LAGOS LAGOS 2.34707E+12 arit.onwusah@novartis.com Sandoz S.R.L., Str. Livezeni nr.7A, 540472, Targu Mures, Romania, Str. Livezeni nr.7A, 540472, Targu Mures, Romania, Romania 25/05/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N05AH03 Olanzapine N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AH Diazepines, oxazepines and thiazepines
Discover more medicines within N05AH03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-100403, A4-100404, A4-100405

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.